This opinion cited by 19 cases:
In Re: Loestrin 24 FE v. ( 2016 )
In re: Ciprofloxacin Hydrochloride Antitrust Litig. ( 2010 )
In Re K-Dur Antitrust Litigation , 686 F.3d 197 ( 2012 )
In re: Ciprofloxacin Hydrochloride Antitrust Litigation ( 2010 )
Arkansas Carpenters Health & Welfare Fund v. Bayer AG , 604 F.3d 98 ( 2010 )
Arkansas Carpenters Health & Welfare Fund v. Bayer AG , 625 F.3d 779 ( 2010 )
Xitronix Corporation v. Kla-Tencor Corporation , 882 F.3d 1075 ( 2018 )
FTC v. Watson Pharmaceuticals, Inc. , 611 F. Supp. 2d 1081 ( 2009 )
Chandler v. Phoenix Services LLC ( 2021 )
Princo Corp. v. International Trade Commission , 616 F.3d 1318 ( 2010 )
In re Cipro Cases I & II , 61 Cal. 4th 116 ( 2015 )
In re: Lipitor Antitrust Lit v. , 855 F.3d 126 ( 2017 )
Xitronix Corporation v. Kla-Tencor Corporation , 892 F.3d 1194 ( 2018 )
Xitronix Corporation v. KLA-Tencor Corporation , 916 F.3d 429 ( 2019 )
In Re Androgel Antitrust Litigation (No. II) , 687 F. Supp. 2d 1371 ( 2010 )
F.T.C. v. Actavis, Inc. , 133 S. Ct. 2223 ( 2013 )
KING DRUG CO. OF FLORENCE, INC. v. Cephalon, Inc. , 702 F. Supp. 2d 514 ( 2010 )
Federal Trade Commission v. Bisaro , 757 F. Supp. 2d 1 ( 2010 )
Federal Trade Commission v. Bisaro ( 2010 )
